nafronyl has been researched along with Asphyxia in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Asphyxia: A pathological condition caused by lack of oxygen, manifested in impending or actual cessation of life.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Estler, CJ | 1 |
| Böcker, R | 1 |
| Schinzel, W | 1 |
1 other study available for nafronyl and Asphyxia
| Article | Year |
|---|---|
Effect of naftidrofuryl on high energy phosphates, glycogen, lactate and pyruvate in mouse hearts during asphyxia and post-asphyctic recovery.
Topics: Adenosine Triphosphate; Animals; Asphyxia; Energy Metabolism; Furans; Glycogen; Heart; Lactates; Mal | 1980 |